|
|
|
|
Cardiomyopathy Medical and Health News Headlines
|
|
|
|
|
|
|
All Recent Cardiomyopathy Medical Condition News Headlines |
|
|
|
|
Aastrom Announces Treatment of Final Patient in IMPACT-DCM Surgical Clinical Trial
Six-Month Interim Results in Study of Patients With Severe Cardiovascular Disease to be Presented Later This Year
ANN ARBOR, Mich., March 9, 2010 --(HSMN NewsFeed) -- Aastrom Biosciences, Inc. (Nasdaq:ASTMD ), a leading developer of autologous cellular ... Regenerative Medicine, CardiologyAastrom Biosciences, cardiomyopathy, heart failure, autologous cell, stem cell (Source: HSMN NewsFeed)...
POSTED 03/09/2010 at 09:32 AM --
|
Unusual Features of Apical Hypertrophic Cardiomyopathy
In conclusion, apical HC in a teaching hospital without a specialized HC clinic and in a predominantly Caucasian population is a disease of the elderly. Documented late morphologic evolution is not uncommon, with a high incidence of coronary fistulae and morbid atrial fibrillation. (Source: The American Journal of Cardiology)...
POSTED 03/09/2010 at 07:57 AM --
|
Aastrom Announces Treatment of Final Patient in IMPACT-DCM Surgical Clinical Trial
ANN ARBOR, Mich., March 9, 2010 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTMD), a leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today reported the final patient treatment in the company's ongoing U.S. Phase 2 surgical clinical trial designated IMPACT-DCM. Treated at Emory University Hospital Midtown in Atlanta, GA, this patient received direct injections of Aastrom's tissue repair cells for the treatment of dilated cardiomyopathy (DCM), a severe form of congestive heart failure in which the heart becomes weakened and enlarged and cannot pump blood efficiently. With the treatment of the final patient in this trial, Aastrom is positioned to report six-month interim data on all enrolled patients later this year. (Source: ......
POSTED 03/09/2010 at 07:30 AM --
|
Coronary Sinus Shocking Lead As Salvage In Patients with Advanced CHF and High Defibrillation Thresholds
Conclusion: This approach is suggested as a salvage option for those problematic patients who have unacceptable DFT results at implantation of an endovascular ICD system. (PACE 2010; 1[ndash]6) (Source: Pacing and Clinical Electrophysiology : PACE)...
POSTED 03/08/2010 at 06:00 PM --
|
Adiponectin downregulation implicated in heart failure
Levels of adiponectin are reduced in patients with both dilated cardiomyopathy and impaired coronary function, study findings show. (Source: MedWire News - Lipidology)...
POSTED 03/08/2010 at 06:00 PM --
|
Racial and Ethnic Differences in Hospice Use Among Patients With Heart Failure [Original Investigation]
Conclusions In a national sample of Medicare beneficiaries with heart failure, blacks and Hispanics used hospice care for heart failure less than whites after adjustment for individual and market factors. To understand the mechanisms underlying these findings, further examination of patient preferences and physician referral behavior is needed. (Source: Archives of Internal Medicine)...
POSTED 03/08/2010 at 02:50 PM --
|
A Young Patient with Danon Disease Receives Two ICD Shocks: Why?
We report the case of an 18-year-old man with Danon disease, a genetic disorder inclunding a severe hypertrophic cardiomyopathy with very broad QRS, who had an implantable cardioverter defibrillator for primary prevention. Nine months after implantation, he received two inappropriate shocks due to R-wave double counting during sinus tachycardia. We discuss how to avoid such inappropriate therapy. (PACE 2010; 1[ndash]2) (Source: Pacing and Clinical Electrophysiology : PACE)...
POSTED 03/07/2010 at 06:00 PM --
|
Use of an Active-Fixation Coronary Sinus Lead to Implant a Biventricular Pacemaker via the Femoral Vein.
Authors: Shandling A, Donohue D, Tobias S, Wu I, Brar R
Cardiac resynchronization therapy, which involves the placement of a pacing lead in the right atrium and in each ventricle, is effective in treating heart failure that is caused by left bundle branch block and cardiomyopathy. The left ventricular lead is usually placed into a lateral branch of the coronary sinus via the subclavian route. When the subclavian route is unavailable, insertion of a standard, passive-fixation coronary sinus lead via the femoral approach is feasible; however, the likelihood of subsequent dislodgment is high. Herein, we describe the placement of a novel, self-retaining, active-fixation coronary sinus lead-the Attain StarFix(R) Model 4195 OTW Lead-in an elderly heart-failure patient, via the femoral approa......
POSTED 03/06/2010 at 05:20 PM --
|
Takotsubo cardiomyopathy: what is behind the octopus trap?
Authors: Angelini P
PMID: 20200634 [PubMed - in process] (Source: Texas Heart Institute Journal)...
POSTED 03/06/2010 at 05:20 PM --
|
Induction of Manganese Superoxide Dismutase by Nuclear Translocation and Activation of SIRT1 Promotes Cell Survival in Chronic Heart Failure [Molecular Bases Of Disease]
Oxidative stress plays a pivotal role in chronic heart failure. SIRT1, an NAD+-dependent histone/protein deacetylase, promotes cell survival under oxidative stress when it is expressed in the nucleus. However, adult cardiomyocytes predominantly express SIRT1 in the cytoplasm, and its function has not been elucidated. The purpose of this study was to investigate the functional role of SIRT1 in the heart and the potential use of SIRT1 in therapy for heart failure. We investigated the subcellular localization of SIRT1 in cardiomyocytes and its impact on cell survival. SIRT1 accumulated in the nucleus of cardiomyocytes in the failing hearts of TO-2 hamsters, postmyocardial infarction rats, and a dilated cardiomyopathy patient but not in control healthy hearts. Nuclear but not cytoplasmic SIRT1......
POSTED 03/05/2010 at 08:37 AM --
|
Cardiomyopathy: A disease of your heart muscle
Cardiomyopathy — Comprehensive overview covers symptoms and treatment of this heart muscle condition. (Source: MayoClinic.com Full Feed)...
POSTED 03/05/2010 at 12:00 AM --
|
Diminished Cardiac Fibrosis in Heart Failure is Associated with Altered Ventricular Arrhythmia Phenotype
Conclusion: Attenuated ventricular fibrosis is associated with reduced VT inducibility, increased VT duration, and significantly longer arrhythmia cycle length. (J Cardiovasc Electrophysiol, Vol. pp. 1[ndash]7) (Source: Journal of Cardiovascular Electrophysiology)...
POSTED 03/04/2010 at 06:00 PM --
|
Hypertrophic cardiomyopathy: from genetics to treatment
Conclusions The clinical phenotype of 'HCM' results from mutations in sarcomeric proteins and subsequent activation of multiple cellular constituents including signal transducers. We advocate that HCM, despite its current recognition and management as a single disease entity, involves multiple partially independent mechanisms, despite similarity in the ensuing phenotype. To treat HCM effectively, it is necessary to delineate the underlying fundamental mechanisms that govern the pathogenesis of the phenotype and apply these principles to the treatment of each subset of clinically recognized HCM. (Source: European Journal of Clinical Investigation)...
POSTED 03/03/2010 at 06:00 PM --
|
Gene Deletion Screen for Cardiomyopathy in Adult Drosophila Identifies a New Notch Ligand.
Conclusions: In conclusion, we identify a previously unknown Notch ligand in Drosophilab that when deleted causes cardiomyopathy. Our study suggests that Notch signaling components may be a therapeutic target for dilated cardiomyopathy.
PMID: 20203305 [PubMed - as supplied by publisher] (Source: Circulation Research)...
POSTED 03/03/2010 at 06:00 PM --
|
The diabetic cardiomyopathy
Abstract Diabetic cardiomyopathy has been defined as “a distinct entity characterized by the presence of abnormal myocardial performance
or structure in the absence of epicardial coronary artery disease, hypertension, and significant valvular disease”. The diagnosis
stems from the detection of myocardial abnormalities and the exclusion of other contributory causes of cardiomyopathy. It
rests on non-invasive imaging techniques which can demonstrate myocardial dysfunction across the spectra of clinical presentation. The presence of diabetes is associated with an increased risk of developing heart failure, and the 75% of patients with unexplained
idiopathic dilated cardiomyopathy were found to be diabetic. Diabetic patients with microvascular complications show the stronges......
POSTED 03/03/2010 at 02:51 AM --
|
The p.A897KfsX4 frameshift variation in desmocollin-2 is not a causative mutation in arrhythmogenic right ventricular cardiomyopathy
Authors: Marzia De Bortoli, Giorgia Beffagna, Barbara Bauce, Alessandra Lorenzon, Gessica Smaniotto, Ilaria Rigato, Martina Calore, Ilena E A Li Mura, Cristina Basso, Gaetano Thiene, Gerolamo Lanfranchi, Gian Antonio Danieli, Andrea Nava
& Alessandra Rampazzo (Source: European Journal of Human Genetics)...
POSTED 03/02/2010 at 06:00 PM --
|
Adding ECG Picks up Abnormalities Not Detected by Physical Exam and Medical History
Researchers say the physical examination, medical history, and 12-lead ECG were "complementary," with the exam and history detecting individuals with valvular disease, while the ECG picked up myocardial abnormalities, including hypertrophic cardiomyopathy. Still, one expert says there are too many obstacles to establishing mandatory preparticipation screening with ECGs. Heartwire (Source: Medscape Today Headlines)...
POSTED 03/02/2010 at 05:30 PM --
|
Aldosterone Antagonists in Patients With Heart Failure [Letters]
(Source: JAMA)...
POSTED 03/02/2010 at 02:50 PM --
|
Aldosterone Antagonists in Patients With Heart Failure [Letters]
(Source: JAMA)...
POSTED 03/02/2010 at 02:50 PM --
|
Aldosterone Antagonists in Patients With Heart Failure--Reply [Letters]
(Source: JAMA)...
POSTED 03/02/2010 at 02:50 PM --
|
|
|
|
|
|
 |
|
|
|
|
|
IMPORTANT NOTICE:
The information provided on this site is intended for your general knowledge only and is not a substitute for professional
medical advice or treatment for specific medical conditions. You should not use this information to diagnose or treat a health problem or disease without consulting with a
qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition.
|
|
|
|
|
|
|
|
Featured Product! |
 |
|
Total Balance
Men's Plus |
|
"The restoration and maintenance of normal organ and brain function, a strong immune system, and the balancing of hormones is the key to vibrant health and in avoiding premature-aging!" |
|
CLICK HERE
for more info... |
|
|
